Literature DB >> 10351926

Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease.

S A Comhair1, M J Lewis, P R Bhathena, J P Hammel, S C Erzurum.   

Abstract

Reactive oxygen species (ROS) are mediators of chronic tissue damage and fibrosis. Endogenous antioxidants may increase in response to oxidants and reduce tissue injury. We investigated the antioxidant response of the lungs to the chronic release of ROS, as occurs in the immune-specific granulomatous inflammation of chronic beryllium disease (CBD), and compared it with that in healthy controls and individuals exposed to cigarette smoke. The antioxidants superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), and glutathione (GSH) were quantitated in lung epithelial lining fluid (ELF) and serum from control subjects (n = 10), cigarette smokers (n = 8), and individuals with CBD (n = 9). GPx activity and extracellular GPx (eGPx) protein were increased in the ELF of subjects with CBD in comparison with that of control subjects and smokers (eGPx in ELF: controls, 1.3 +/- 0.2 microgram/ml, smokers, 1.9 +/- 0.3 microgram/ml, CBD, 3.8 +/- 0.8 microgram/ml; p = 0.002; GPx U/ml ELF, controls 1.4 +/- 0.3, smokers 1.8 +/- 0.4, CBD, 4.5 +/- 1, p = 0.02). Smokers' ELF had higher levels of GSH than that of controls, but CBD patients' ELF contained much more GSH than that of either controls or smokers (p < 0.001). Increases in GSH were correlated with eGPx, indicating similar inducing mechanisms for these antioxidants. Thus, coordinate augmentation of the glutathione antioxidant system occurs in granulomatous lung inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10351926     DOI: 10.1164/ajrccm.159.6.9810044

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

Review 1.  Chronic beryllium disease: an updated model interaction between innate and acquired immunity.

Authors:  Richard T Sawyer; Lisa A Maier
Journal:  Biometals       Date:  2010-10-28       Impact factor: 2.949

Review 2.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

Review 3.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

Review 4.  Lack of association between physical activity in smokers and plasma glutathione peroxidase levels.

Authors:  Andrew Rundle; Catherine Richards; Deliang Tang; Frederica Perera
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04       Impact factor: 4.254

5.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.

Authors:  Suzy A A Comhair; Kristin S Ricci; Mercedes Arroliga; Abigail R Lara; Raed A Dweik; Wei Song; Stanley L Hazen; Eugene R Bleecker; William W Busse; Kian Fan Chung; Benjamin Gaston; Annette Hastie; Mark Hew; Nizar Jarjour; Wendy Moore; Stephen Peters; W Gerald Teague; Sally E Wenzel; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

6.  Elevated levels of NO are localized to distal airways in asthma.

Authors:  John T Anderson; Meiqin Zeng; Qian Li; Ryan Stapley; Doyle Ray Moore; Balachandra Chenna; Naomi Fineberg; Jaroslaw Zmijewski; Isam-Eldin Eltoum; Gene P Siegal; Amit Gaggar; Stephen Barnes; Sadanandan E Velu; Victor J Thannickal; Edward Abraham; Rakesh P Patel; Jack R Lancaster; David D Chaplin; Mark T Dransfield; Jessy S Deshane
Journal:  Free Radic Biol Med       Date:  2011-03-16       Impact factor: 7.376

7.  Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice.

Authors:  Leonard W Velsor; Chirag Kariya; Remy Kachadourian; Brian J Day
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-08       Impact factor: 6.914

8.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity.

Authors:  Suzy A A Comhair; Weiling Xu; Sudakshina Ghosh; Frederik B J M Thunnissen; Alexandru Almasan; William J Calhoun; Allison J Janocha; Lemin Zheng; Stanley L Hazen; Serpil C Erzurum
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 9.  Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases.

Authors:  V L Kinnula
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

10.  Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease.

Authors:  Dave R Dobis; Richard T Sawyer; May M Gillespie; Jie Huang; Lee S Newman; Lisa A Maier; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2008-01-24       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.